Market Pulse
KIS quote snapshot · Sep 21, 2026 09:30 KST · KIS quote snapshots + ECOS · 30 min refresh
KOSPI
6,963.15
+68.92 (+1.00%)
KOSDAQ
829.65
+2.53 (+0.31%)
KOSPI 200
1,103.82
+13.59 (+1.25%)
USD/KRW
1,383.30
326030KOSPI·May 13, 2025
Concerns are overblown
Mirae Asset Securities published a company analysis report on SK Biopharmaceuticals (326030) titled "Concerns are overblown".
Summary
Covers SK Biopharmaceuticals (326030).
Covered stock
More on 326030
Two concerns addressed; focus now turns to RISE3 dataMirae Asset Securities · Aug 27, 2026Solid earnings; adding a second product could unlock further upsideMirae Asset Securities · Aug 07, 2026Initiating Coverage: Xcopri’s Run; Securing New Growth Engines is NextKB Securities · May 27, 2026Strong 1Q26 earnings outlook vs. full-year cost pressuresMirae Asset Securities · Feb 09, 2026Strong 2Q25 results ease concernsMirae Asset Securities · Aug 06, 2025Leading the wayMirae Asset Securities · Feb 07, 2025